-
Novartis is collaborating with Microsoft to apply machine learning to medicinal chemistry — part of an effort to leverage AI to bring treatments to patients more efficiently.
Biomedical ResearchData ScienceDrug DevelopmentDrug DiscoveryEmerging Technology -
Basel, June 24, 2020 — Novartis revealed the healthcare and pharma industry has emerged as a desired career destination for tech talent during the COVID-19 pandemic, in the Powerful Pairing research report launched today.Reimagine MedicineInnovationDigitalData Science
-
Two Novartis leaders share their perspectives on digital health in 2020 – and the key trends to watch out for over the next 12 months.
Data ScienceFuture of HealthcareInnovationMedical Innovations -
AI is already accelerating drug discovery and health delivery. It has great potential to accelerate research, workflow and processes, and even reengineer entire healthcare systems. But what challenges must be addressed first? Shahram Ebadollahi and Ann Aerts share the ideas they discussed at the Intelligent Health summit in Basel this week.
Access to HealthcareData ScienceDigitalEmerging TechnologyGlobal Health Partnerships -
Novartis researchers are using data to accelerate drug development.
Data ScienceDigitalDrug DiscoveryInnovation -
The recently appointed leader of the Novartis’ digital research and development platform data42 is a strong believer that data and digital technologies will change the path of medical science.
Data ScienceDigitalEmerging TechnologyFuture of HealthcareInnovation -
Novartis is betting on both human inquisitiveness and computer expertise to harness the wealth of its digital research and development platform, data42.
Data ScienceDigitalEmerging TechnologyFuture of HealthcareInnovation -
Novartis CEO Vas Narasimhan answers questions about COVID-19.
Biomedical ResearchCOVID-19Data ScienceDiseasesInfectious DiseasesClinical TrialsBiomedical Science